Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor by unknown
ANTIGEN-SPECIFIC  T  CELL-MEDIATED  SUPPRESSION 
V.  H-2-1inked Genetic Control of Distinct Antigen-specific 
Defects in the Production and Activity of 
L-Glutamic AcidS°-L-Tyrosine  5° Suppressor Factor* 
BY RONALD N. GERMAIN, CARL WALTENBAUGH,~ AND BARUJ BENACERRAF 
From the Department  of Pathology, Harvard Medical School, Boston, Massachusetts  02115 
The signals which  activate  suppressor T  cells  (Ts) x are  poorly understood.  Thus, 
although a wide array of procedures is known for inducing Ts responses (e.g., the use 
of deaggregated protein antigens, [1, 2], antigens coupled to syngeneic cells [3-6], low 
doses of intravenous  antigen  in vivo [7], or high concentrations  in vitro [8-11], with 
or without macrophage depletion), no common cellular or molecular basis for such Ts 
induction  is  apparent  from  this  information.  In  particular,  the  issues  of antigen 
presentation  on cell membranes and of H-2 restriction  of Ts activity are unresolved. 
This stands  in marked  contrast  to the well-documented  H-2K, D, or I  influence on 
antigen  recognition  and/or  T  cell  activation  seen  in  studies  of other T  cell  subsets 
(12-14),  and  the  importance  of non-T  cells  bearing  these  H-2  products  for  both 
peripheral  triggering and thymic differentiation  (12-16).  Only in a  few cases has H- 
2  restriction  been  observed  in  studies  on Ts  (17-21),  and  these  findings  are  by no 
means generalizable at present, in part because of conflicting results, and also because 
of the ease of demonstrating  Ts binding to antigen  in  the absence of H-2 products 
(22-24). This problem is made more intractable because of the difficulty of designing 
experiments to test H-2 restriction of Ts at the cell level, caused  (a)  by the absence of 
a clear-cut antigen priming and restimulation test similar to T  cell proliferation assays 
used to explore the role of Ia in macrophage-T cell interaction,  (b) by the fact that Ts 
appear to act on other T  cells  (25-27), thus precluding most cell mixing experiments 
to test  for H-2restriction,  because  of complicating allogeneic  effects,  and  (c)  by the 
paucity of models  demonstrating  antigen-specific  genetic  control of Ts  function,  in 
contrast with the numerous immune response  (Ir) gene models so crucial to develop- 
ment of current  theories of helper cell function (28). 
This laboratory has focused on this last issue as a potential means of resolving some 
of the  questions  concerning  Ts  activity,  by studying  the  response  to  the  synthetic 
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polypeptide  antigen,  L-glutamic  acidS°-L-tyrosine  s°  (GT).  No  inbred  mice  give  a 
primary plaque-forming cell (PFC) response to GT, but strains fall into two categories, 
those which show GT-specific suppression  (H-2  d's'k) and those which do not (H-2  a'b'q) 
(29,  30).  This suppressor response is under the control of two I  region genes, termed 
immune suppression  (Is) genes, tentatively mapped to the I-A and I-C subregions (31, 
32).  GT-induced  Ts  yield  a  soluble  suppressor  factor  (TsF)  which  has  an  antigen- 
binding site,  bears  I-J subregion-coded  determinants,  has a  mol wt of ~50,000,  and 
functions  in  large  measure  by inducing,  together with  antigen,  a  second set  of Ts, 
termed Ts21 from unprimed syngeneic or allogeneic T  cell populations  (33-36). 
The  discovery  of  two  discrete  steps  in  the  suppressor  pathway,  namely,  TsF 
production,  and  Ts2  generation,  suggested  the  possibility  of a  heterogeneity  in  the 
locus of the  Is  defects  in  GT  nonsuppressor  strains.  Previous  studies  have  revealed 
that at least one strain, A/J  (H-2a), can be shown to lack the ability to produce GT- 
TsF,  but  to retain  the ability to generate Ts2 upon exposure to active GT-TsF  (37). 
Furthermore,  it  has been  found that  F1 hybrids or intra-H-2  recombinants  between 
H-2  a  and  H-2  b  nonsuppressor  strains  complement  to  produce  GT-suppressor  mice 
(32).  This  indicated  that  H-2  b mice might  have a  distinct  defect  from that  of A/J, 
and  would  be  TsF  producers  unable  to  be  suppressed  by  this  factor.  The  present 
report  documents  that  this  prediction  is  correct,  and  that  these complementing Ys 
defects are under H-2 (Is) control. The implications of these data for understanding 
initial Tsl triggering, and subsequent Ts~-Ts2 communication, are discussed. 
Materials  and Methods 
Animals.  C57BL/6  (B6,  H-2b),  A/J  (H-2"),  (B6  ×  A/J)Fx  [(B6AF~),  H-2b/"],  C57BL/10 
(B 10, H-2b), A.BY (H-2b), B 10.A (H-2~), and SJL (H-2  s) mice were purchased from the Jackson 
Laboratory, Bar Harbor, Maine. BALB/c (H-2  d) mice were purchased from Health Research, 
Inc., West Seneca, N. Y. All mice were maintained on standard laboratory chow and acidified 
water ad lib., and used at 8-20 wk of age. 
Antigens.  The random copolymers GT  (lot  9, mol wt  ~130,000)  and  L-glutamic acid6°-L  - 
alaninea°-L-tyrosine  1° (GAT, lot 6, mol wt ~32,500)  were purchased from Miles Laboratories, 
Inc., Elkhardt,  Ind.  Methylated  bovine serum albumin  (MBSA)  was purchased  from either 
Sigma Chemical Co., St. Louis, Mo., or Worthington Biochemical Corp., Freehold, N. J. Sheep 
blood was purchased from Gibco Diagnostics, Chagrin Falls,  Ohio. GAT and GT solutions, 
MBSA complexes, and GAT-conjugated sheep red blood cells (GAT-SRBC) were prepared as 
previously described (29). 
Preparation of TsF.  GAT-TsF and GT-TsF were prepared as previously described (33, 38). 
In brief,  mice serving as donors of cells  for suppressor factor preparation  were primed  with 
either 10 #g GAT or 100/~g GT in Maalox (aluminum-magnesium hydroxide gel, Wm. Rorer, 
Inc., Fort Washington, Pa.) intraperitoneally, 3-7 d before use. These mice were then sacrificed, 
their spleens  and thymuses removed, teased in balanced salt  solution to provide a single cell 
suspension, washed,  and suspended  at  6  ×  108/ml.  This suspension  was sonicated  (50 W, 5 
min) using a Sonifier Cell Disrupter  (Ultrasonics Industries, Westbury, N.  Y.) with microtip, 
and the resulting material centrifuged at 40,000 g for 1 h at 4°C. The supernatant was recovered 
and frozen at -60°C until use. This constituted (crude) GAT-TsF or GT-TsF. Similar extracts 
from mice given Maalox alone served as control factors. 
Assay of TsF Activity.  The presence or absence of suppressor factor in a  given extract was 
assayed as previously described (36, 39). In short, direct suppression was assessed by addition 
of GT-TsF to modified Mishell-Dutton cultures, stimulated with GT-MBSA, and assayed on 
day 5 for IgG PFC using GAT-SRBC. Induction of Ts2 was assessed by incubating spleen cells 
with  GT-TsF for 2 d, washing the cultured  cells,  and  transferring  graded  numbers  to new 
Mishell-Dutton cultures, which were then stimulated and assayed as described above. Data are 
expressed as specific IgG PFC/culture, assayed on GAT-SRBC. Standard errors (usually < 10%) R.  N. GERMAIN, C. WALTENBAUGH, AND B.  BENACERRAF 
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A/J and B6 Nonsuppressor Strains Complement  for GT-Suppression in (B6A  )Ft Mice 
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Strain  Preimmuniza-  Challenge:[:  PFC/spleen§  Percentage of sup- 
tion*  pression 
% 
A/J  None  50 #g GT-MBSA  5,900 ±  159l  -- 
100 gg GT  50 gg GT-MBSA  4,000 ±  902  3211 
B6  None  50 #g GT-MBSA  7,050 ±  2576  -- 
100 gg GT  50/tg GT-MBSA  7,325 ±  1359  0 H 
(B6A)FI  None  50 ~g GT-MBSA  6,200 ±  2193  -- 
100 gg GT  50 ~g GT-MBSA  225 ±  14  96¶ 
* 100 gg GT in Maalox intraperitoneally 4 d before challenge. 
:~ 50/~g GT as GT-MBSA in Maalox-pertussis intraperitoneally 7 d before assay. 
§ Specific IgG PFC/spleen assayed on GAT-SRBC. Four animals per group. 
II P > 0.3. 
~1 P = 0.03. 
are omitted for clarity. Ts2 induction was also assayed by transferring the washed cultured cells 
(4 ×  106) into syngeneic recipients, which were then challenged i.p. with either 20 gg of GAT 
or 50 gg of GT  as GT-MBSA in 0.2  ml of saline containing 5%  Maalox and  109 B. pertussis 
organisms (Eli Lilly, Indianapolis, Ind.) as adjuvant. Specific PFC were determined 7 d  later 
using GAT-SRBC.  Data  are  reported as  PFC/spleen ±  SEM.  All  indicated differences are 
significant at the P <  0.05 level, using Student's t test. 
Results 
(B6A)Ft and B6, but Not A/J, Mice Produce Detectable GT-TsF.  The data in Table I 
confirm previous studies (31, 32) showing B6 and A/J mice to be GT nonsuppressors, 
but  nonetheless  to possess Is genes  able to complement  for suppression  in  (B6A)F1 
animals. These findings, together with the information that A/J mice do not produce 
detectable  GT-TsF, suggest  that  (B6A)F1  mice can  produce  and  be suppressed  by 
GT-TsF, and that either both A/J and B6 contribute genes, which  are necessary for 
both TsF generation and activity, or that the B6 mouse can produce GT-TsF, but not 
be suppressed  by  it.  In  the  FI,  the  two  parts  of the  complete  pathway  would  be 
brought together, yielding a suppressor animal. To test these hypotheses, extracts were 
prepared from spleens and thymuses of GT-primed A/J, B6, and (B6A)F1 mice from 
the same groups of animals used to check suppressor status,  as reported in Table I. 
The  activity of such  extracts  and  control  extracts  from animals  receiving  Maalox 
alone, as assayed by direct suppression of GT-MBSA responses in vitro, is shown in 
Figs.  1 and 2.  Fig.  1 demonstrates that, as predicted,  (B6A)Fx and B6 mice produce 
GT-TsF active on the GT-MBSA response of the suppressor strain BALB/c. However, 
as already demonstrated  (37),  A/J  mice fail to yield active GT-TsF, as assayed on 
BALB/c  cells.  Although  these  cells should  be appropriate  targets  for any GT-TsF 
produced by the A/J cells because no H-2 barriers to GT-TsF activity in suppressor 
strains are known to exist, and in particular, BALB/c GT-TsF is active in A/J mice, 
to verify the absence of GT-TsF in sonicates of GT-primed A/J cells, the F1 and A/J 
extracts were also retested on (B6A)Fx cells. Such Fx cells are the most likely candidate 
for an appropriate target for any cryptic A/J GT-TsF. As shown in Fig. 2, the Fa GT- 
TsF had the expected activity on  Fx cells,  but  the A/J material was still  devoid of 
suppressive potential.  Although not shown, all factors presented in these figures and 1248  H-2-LINKED  DEFECTS  IN T  SUPPRESSOR  PATHWAYS 
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Flo.  1.  B6 and (B6A)FI, but not A/J, mice produce GT-TsF active on allogeneic BALB/c mice. 
The indicated factors were added at the given final dilutions to cultures of 7.5 ×  10  e BALB/c spleen 
cells stimulated with 2.5 #g GT as GT-MBSA. Specific IgG PFC were assayed on GAT-SRBC 5 d 
later, and are expressed as % control response 
PFC with GT-TsF 
x  100%. 
=  PFC with control extract 
the experiments reported below were tested for nonspecific suppression of SRBC and/ 
or GAT responses, and shown to be specific for GT-MBSA responses. 
A/J,  but Not B6, Mice Can Be Suppressed by GT-TsF, and Generate Active  Ts~ upon TsF 
Exposure.  Earlier  studies  also  demonstrated  that  A/J  mice  could  be  directly sup- 
pressed by GT-TsF from another strain, and yield Ts2 in vivo or in vitro when exposed 
to  such  GT-TsF  (35,  36).  Table  II  shows  that  B6  mice,  in  contrast,  cannot  be 
suppressed directly in  vitro  by  (B6A)F1  TsF.  This  defect  is expected  since in  mice 
which produce GT-TsF, nonsuppressor status must result from a  functional failure of 
TsF activity. 
The  ability of the  nonsuppressor  strain  B6  to  produce  GT-TsF  active  in  direct 
suppression of other strains raised the question of whether  (a)  this active extract also 
could cause Ts2 induction, and (b) if so, whether the defect in B6 mice responsible for 
their nonsuppressor status was the inability to generate functional suppression at the 
Ts2 or later stages in the pathway.  It has already been shown  that GAT-TsF fails to 
suppress  directly GAT  responder  mice,  but  nonetheless  can  induce  Ts2  which  are 
active in such responder animals  (40). To explore these issues, in vitro generation of 
Ts2 was attempted using (B6A)F1 and B6 GT-TsF as well as extracts from GT-primed 
A/J  mice.  As shown  in  Fig.  3,  B6  GT-TsF,  but  not  the  A/J  extract,  could  induce 
active Ts2 using A/J cells in vitro, which were able to suppress the GT-MBSA response 
of syngeneic A/J  mice. Fig. 4  reveals, however,  that  although  both  B6 and  (B6A)F] 
GT-TsF induce Ts2 using A/J spleen cells, neither suppressor factor preparation can 
cause B6 spleen cells to become active suppressors. These data indicate either a  failure 
of GT-TsF to produce Tsz, or a  failure of such Ts2 to be able to mediate suppression, 
in B6 mice. 
Specificity  of the  B6  D~ect  in  TsF Activity.  Because  I  region  genetic  control  of R.  N.  GERMAIN,  C.  WALTENBAUGH, AND B.  BENACERRAF 
EXTRACT TESTED 
SOURCE  DILUTION  TYPE 
[  (BEA)F  I RESPONSE TO GT-MBSA IN VITRO 
None  None  None 
I/tO0 l-Control 
AIJ-J  -L  GT-Ts  F 
L1/  [-Control 
300-1_  GT-Ts  F 
1/300  I- Control  I  ~_ GT-Ts  F 
(B6A)F~--I 
L  1/900  __[  -control 
~_ GT-Ts  F 
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SPECIFIC JgG  PFC/CUL  TURE 
Flo.  2.  Extracts from OT-immunized A/J mice fail to suppress  (B6A)Fl-responding  spleen  cells. 
The protocol was the same as for Fig.  1, except data are expressed  as PFC/culture of 7.5  x  106 
(B6A)FI cells. 
TABLE  II 
Failure of (B6A  )F1 GT-TsF to Suppress Directly B6 GT-MBSA PFC Responses in  Vitro 
Responding spleen  Antigen:]:  (B6A)FI  Specific PFC/  Percentage of sup- 
cells*  GT-TsF§  culture]l  pression¶ 
% 
(B6A)F1  5 #g GT-MBSA  -  215  -- 
(B6A)F1  5 #g GT-MBSA  +  < 10  >95 
A/J  5 #g GT-MBSA  -  220  -- 
A/J  5/~g GT-MBSA  +  <10  >95 
B6  5 #g GT-MBSA  --  275  -- 
B6  5/~g GT-MBSA  +  370  0 
* 7.5 ×  106 cells/1 ml modified Mishell-Dutton culture. 
:~ 5 #g GT as GT-MBSA added per 1 ml culture. 
§ -, no factor added; +, 1/900 final dilution of (B6A)FI GT-TsF in the culture. 
II Specific IgG PFC/eulture on day 5, assayed on GAT-SRBC. 
¶ Compared with group without TsF. 
immunity  is  typically  a  highly  antigen-specific  phenomenon  (28),  the  specificity  of 
the defect in TsF activity in B6 mice was investigated. As noted above, GAT responder 
mice  can  be  suppressed  by  nonresponder-derived  GAT-TsF  if  such  TsF  is  first 
permitted  to induce GAT-Ts2, either in  vivo or in  vitro  (40).  Thus,  the ability of B6 
(GAT  responder)  mice  to  yield  Ts2  active  in  suppressing  GAT  responses  upon  co- 
culture with GAT-TsF  was tested. SJL mice, which are suppressors  for both GAT  and 
GT,  were used  to prepare  GAT-TsF  and  GT-TsF,  to avoid any  complicating effects 
caused  by  use  of TsF  derived  from  different  strains  of mice.  B6  spleen  cells  were 1250  H-2-LINKED DEFECTS  IN T  SUPPRESSOR  PATHWAYS 
TREATMENT  IN CULTURE 
NUMBER 
TRANSFERRED 
1/200 B6 Control  Extract  4x 106 
1/200  B6  GT-TsF  4x IO  s 
I A/J RESPONSE  TO GT-MBSA IN VIVO 
Control  Extract  4x I0  e  I  1/200  A/J 
I: 
,12oo A/J  GT-TsF  4x,O  
1  I  I  I  I  I  I 
o  2,000  4,000  6,000 
SPECIFIC /gG  PFC/  SPLEEN 
Fxo.  3.  Extracts from OT-primed B6, but not A/J, mice induce GT-Ts2. A/J normal spleen cells 
were incubated for 2 d in vitro with 1/200  final dilutions of the indicated extracts.  The recovered 
cells  were washed  and  4  X  106  viable cells  transferred  intravenously  into  each  syngeneic  A/J 
recipient, which was then challenged with 50 #g GT as GT-MBSA in Maalox-pertussis  adjuvant. 
Specific IgG PFC were assayed on GAT-SRBC 7 d later, and the data are expressed as PFC/spleen 
+  SEM. 
TREATMENT IN  CULTURE 
NUMBER 
TRANSFERRED 
1/200  Conlrol Extract  4 x tO  6 
11200 (B6A)FI GT-TsF  4 x 106 
1/200  B6  GT-TsF  4 x 106 
I B6 RESPONSE TO GT-MBSA IN  VIVO 
k iiii!iiiiiiiiiiiiiiiiiiiiii!iiiiiiiiiiiii!iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii iii i  i ii i i i!!!iiiiiiii  
11200  Control  Extract  4 xlO  e 
1/200 (B6A)F~ GT-TsF  4 x 106 
1/200  B6  GT-TsF  4 x 106 
A/J RESPONSE TO 6T-MBSA IN VIVO 
 !i  !i  iii i! !i  ii  ii iiiiiiiiiiiiiiii iiii ii!iiii!iii iiii!iiiiiiii  iii!i iiiiiiii iiiiiiii  
I  I  I  [  I  I  ] 
0  2,000  4,000  6,000 
SPECIFIC /gG  PFC/SPLEEN 
Ext.  4.  A/J, but not B6, spleen cells show functional Ts2 activity after exposure  to GT-TsF. Same 
basic protocol as in Fig. 3. 
incubated for 2 d  in either factor, washed, and transferred in vivo into separate groups 
of B6  mice  which  were  challenged  either  with  GAT  or  GT-MBSA.  As  a  positive 
control,  A/J  cells were cultured  in  SJL GT-TsF  and  transferred  to A/J  mice which 
were  challenged  with  GT-MBSA.  The  results  of one  of several  such  experiments, 
shown in Fig. 5, clearly demonstrate  that  the defect in B6 mice is exquisitely antigen 
specific. Thus, only GT-TsF  fails to induce active Ts2 in B6 mice; GAT-TsF  yields Ts2 
which efficiently suppress  the GAT,  but  not GT-MBSA  response of the B6 mice. The R.  N.  GERMAIN, C.  WALTENBAUGH, AND B.  BENACERRAF 
NUMBER 
TREATMENT IN  CULTURE  TRANSFERRED 
[ B6  RESPONSE TO GT-MBSA IN VIVO 
1/100 SJL Control Extroct  4xlO  6 
1/100 SJL  GT-TsF  4 x IO  s 
1/100 SJL  GAT-TsF  4x 10  s 
B6 RESPONSE TO G4T IN VIVO 
1/100 SJL Control  Exlroct  4 x  tO  6  ~i~iiiiii;i;iiiiiiiiii~ii;iii;iii~iiiiiiiiiiiiiiiiiii~iiiiiiiiiiiiiii~iiiiiiiiii~iii;i~iii~i~iii;i~iiiiiii~i~i~i~ 
I/I00  SJL GT-TsF  4x tO  s  ~//JJ//JJJJJJJJJJJJ~J~ 
l/tO0 SJL GAT-TsF  4xlO  6 
A/J RESPONSE  TO  6T-MBSA IN V/VO 
Ill(X) SJL Control Extroct  4x IO  s  ~ii!iiiii~ii!ii~ii~iiiiii~iiiiiiiii~ii~ii~i~!i~ii~i~iii!~i~iii!iiiii~ii!ii~i~ii!ii~i~iii!i~i1 
1/100 SJL  GT-TsF  4 xlO  6 
I  I  I  I  I  I  I 
0  2,000  4,000  6,000 
SPECIFIC IgG PFC/SPLEEN 
Flo.  5.  The defect in Ts~ activity in B6 mice is antigen specific. Same basic protocol as in Fig. 3, 
except 20/~g of GAT was used to challenge one set of B6 mice. 
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H-2-1inked control of GT-TsF production.  Same basic protocol as in Fig. 1. 
GT-TsF used was active, since it induced potent GT-Ts2 in A/J mice. 
H-2 Linkage of A/J and B6 Prototype Defects.  Over-all suppression induced by GT 
priming is clearly under H-2-1inked Is gene control (29-32). It was therefore expected 
that the selective defects in factor production and activity seen in A/J  and B6 mice, 
respectively,  would  also  be  H-2  linked.  A  limited  series  of experiments  has  been 
performed to test this prediction. Extracts of spleen and thymus have been prepared 
from  GT-primed  B6  (H-2b),  A.BY  (H-2b),  and  B10.A  (H-2  a)  mice,  and  previously 
tested GT-TsF assayed on several of these same strains. As shown in Fig. 6, both H-2 b 
strains  B6  and  A.BY  produce active GT-TsF,  while  B10.A,  an  H-2  a strain,  fails to 1252 
FIG.  7. 
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H-2-1inked control of GT-TsF activity. Same basic protocol as in Fig.  1. 
TABLE  III 
H-2 Control of Direct Suppression Mediated by GT-TsF 
Responding spleen  AntigenS:  A.BY extract  Specific PFC/  Percentage of 
cells*  tested§  culturel]  suppression¶ 
B10 (H-2 b)  5 #g GT-MBSA  Control  270  -- 
B10 (H-2 b)  5 #g GT-MBSA  GT-TsF  833  0 
B 10.A (H-2 a)  5 #g GT-MBSA  Control  705  -- 
B 10.A (H-2 a)  5 p,g GT-MBSA  GT-TsF  15  98 
B 10.BR (H-2 k)  5 p,g GT-MBSA  Control  758  -- 
B10.BR  (H-2 k)  5 #g GT-MBSA  GT-TsF  <15  >98 
A.BY (H-2 b)  5/Lg GT-MBSA  Control  893  -- 
A.BY (H-2 b)  5 #g GT-MBSA  GT-TsF  750  16 
A/J (H-2 a)  5 p,g GT-MBSA  Control  502  -- 
A/J (H-2 a)  5 #g GT-MBSA  GT-TsF  127  75 
* 7.5 x  106/1 ml modified Mishell-Dutton culture. 
~c 5 #g GT as GT-MBSA/1 ml culture. 
§ 1/250 final dilution of control or GT-TsF. 
[1 Specific IgG PFC/culture on day 5, assayed on GAT-SRBC. 
¶ Compared with group receiving control extract. 
yield active GT-TsF,  as was  the case for A/J.  Thus,  the  ability  to  produce  GT-TsF 
correlates  with  H-2  status  (made  by  H-2 b,  not  by  H-2a),  irrespective of background 
genes. Fig. 7 illustrates the converse situation:  B10.A (H-2 a) cells can be suppressed by 
active GT-TsF,  as already shown  for A/J  (H-2a),  while A.BY  (H-2b),  like B6  (H-2b), 
fails to  be suppressed  by  the  same  GT-TsF  preparations.  Table  III shows  the  same 
pattern  with  the  pairs  B10  (H-2b)-B10.A  (H-2  ~)  and  A.BY  (H-2b)-A/J  (H-2  ~)  in  a 
single experiment.  Again,  H-2 b responses  are not suppressed  by GT-TsF,  while H-2  ~ 
responses  are  markedly  reduced  by  the  same  material.  It  should  be  noted  that 
increased  responses  in  H-2 b  mice  to  extracts  from  GT  suppressor  strains  have  been R.  N.  GERMAIN, C.  WALTENBAUGH, AND  B.  BENACERRAF  1253 
seen in several, though not all, experiments, and may reflect the presence of additional 
stimulatory factors in such preparations which are masked in those strains able to be 
suppressed by the predominant GT-TsF component. 
Discussion 
The data presented above document that independent antigen-specific H-2-1inked 
genetic lesions can affect two previously defined steps in suppressor T  cell pathways. 
Thus,  H-2" animals fail to produce  detectable GT-TsF when  challenged  with GT. 
Nevertheless, such  H-2  a animals  possess cells able to mature into  active Ts2, when 
exposed to active GT-TsF from any of several allogeneic sources.  Conversely, H-2  b 
mice produce GT-TsF after GT priming, but neither this factor nor that from other 
strains, can cause suppression of H-2  b responses to GT-MBSA. Either defect (lack of 
TsF production or failure of TsF action) is sufficient to render the animal phenotyp- 
ically a GT nonsuppressor. Combination of H-2" and H-2  b genomes in the form of F1 
mice such as (B6A)F1 is sufficient to restore the ability to demonstrate GT suppression, 
involving GT-TsF generation and activity. 
Several other groups have reported isolated genetic defects in either T  suppressor 
factor  production  or  activity,  but  these  observations  appear  to  differ  from  those 
described above. Thus, Taniguchi et al. (41) have shown that A/J mice fail to produce 
keyhole limpet  hemocyanin  (KLH)-TsF, but can be suppressed  by KLH-TsF from 
other I-J  k mice. In the same model all B10 congenic mice produce KLH-TsF but fail 
to be suppressed by any I-J matched KLH-TsF. Although these defects resemble those 
reported here, Taniguchi et al. found that these KLH-related defects are not linked to 
H-2, but  rather  to  background  genes.  In  addition,  B6  mice can  be suppressed  by 
KLH-TsF, in contrast to GT-TsF. It should also be noted that A/J mice have been 
shown to produce TsF active in some humoral  (42)  and cell-mediated  (43)  immune 
responses, indicating that the defects for KLH and GT do not reflect a general lesion 
at this level in these mice. Rich et al.  (44)  have demonstrated a  failure of B6 mice to 
produce a suppressor factor active in decreasing mixed lymphocyte responses (MLR). 
These  mice  possess  the  structural  gene  for  MLR-TsF,  however,  because  F1  mice 
between  B6  and  BALB/c  yield  TsF  showing  an  I-C restriction  for activity  in  the 
nonproducer strain.  It remains to be seen how these similar but genetically distinct 
defects relate to one another. 
The findings reported in this paper have particular significance for two aspects of 
suppressor  cell  function.  First,  by  documenting  a  genetic  basis  for  the  previously 
proposed Tsl ~  Ts2 model of Ts function, they strengthen the concept of suppression 
as the end result of a series ofT-T interactions involving distinct T  cell subsets. Such 
T  cell circuits have been described by several groups. In the GT and GAT models, it 
was first reported that TsF acted by inducing Ts2, in vivo or in vitro, even in animals 
phenotypically nonsuppressor by virtue of a defect in TsF production  (35,  36, 39, 40, 
45,  46).  This  further  agreed  with  the  finding  that  suppressor  mice,  treated  with 
cyclophosphamide, failed to produce GT-TsF but nonetheless could be suppressed by 
such  suppressor  material,  suggesting  two  distinct  T  cell  populations,  differing  in 
cyclophosphamide sensitivity, involved in suppression (47).  Tada has reported almost 
identical  findings  for KLH-TsF (48).  The target of this factor is a  KLH-primed Ly 
123 + T  cell which adheres to nylon wool, in contrast to the Ly 23 + nylon nonadherent 
TsF producer.  In both models, Ts2 induction  requires both I-J determinant-bearing 1254  H-2-LINKED DEFECTS IN T  SUPPRESSOR PATHWAYS 
factor and specific antigen.  The ability of TsF to induce  new  (Ts2)  suppressors has 
also been demonstrated for tumor-sPecific antigens (49), and for haptens using delayed 
type hypersensitivity models (50).  Finally, the feedback suppression loop described by 
Eardley et al.  (51)  in the response to SRBC also involves T-T interactions which are 
apparently  mediated  by TsF  (52).  Thus,  the  GT model serves as a  prototype of a 
generalizable model for T  cell suppression, in which mice with distinct lesions in each 
step can serve as unique tools for studying selectively the origin of the defect and thus, 
the normal mechanism of Ts activation. 
This  last  point  relates  directly  to  the  issue  of I  region  gene  involvement  in  Ts 
activity. Previous studies have revealed that GT suppression is controlled by at least 
two complementing genes located in the I-A and I-C subregions of H-2 (32).  These 
subregions do not appear to contain structural genes for GT-TsF, a function ascribed 
to a  third gene located in the I-J subregion (34).  It is therefore necessary to consider 
other  possible  ways  in  which  I-A and  I-C  genes  might  control  Ts  activity  in  an 
antigen-specific manner.  To us,  the most likely hypothesis is  that,  in  analogy with 
other T cell subsets, these genes produce cell surface glycoproteins involved in "antigen 
presentation."  BALB/c  (I-A  d,  I-C  a)  mice  and  B10.BR  (I-A  k,  I-C  k)  mice each  can 
produce and be suppressed by GT-TsF (33).  Furthermore, B 10.BR GT-TsF is active 
in BALB/c mice, and BALB/c GT-TsF is active in both B10.BR and A/J mice (37). 
Therefore, it appears that the defect in A/J  (I-A  k, I-C  a) mice for production of GT- 
TsF cannot be ascribed to a problem with either oneor the other Is gene, but must be 
due  to  a  failure  of  the  two  genes  to  interact  appropriately  for  the  postulated 
presentation  function  (i.e.,  this system shows coupled complementation [53]).  Thus, 
in a suppressor system Is control of GT-triggering of Tsl for TsF production would be 
analogous to Ir gene control of Tn activation for the terpolymer L-glutamic acid-L- 
lysine-L-phenylalanine  (53,  54).  Such  a  model  leads  to several  testable predictions. 
First,  in  the  complementing Fa  (B6  ×  A),  successful  GT  presentation  should  elicit 
both I-J  b and I-J  k determinant-bearing TsF, since the postulated defect in A/J is not 
in a  locus affecting TsF structure per se.  For the same reason, the TsF produced by 
the suppressor B10.A(5R)  strain which  has its I-J subregion derived  from the  H-2" 
haplotype,  should  also  be  bound  by anti-I-J  k alloantibodies.  Second,  in  the  same 
(B6A)F1, presentation of GT on parental cells should fail to evoke Tsl activity, whereas 
GT  on  B6  cells  should  trigger  TsF  formation.  The  identity  of  the  hypothetical 
"presenting"  cell  is  totally  unknown,  but  is  likely  to  be a  subpopulation  of either 
macrophages  or  T  cells.  Furthermore,  the  relevant  Ia  molecule  involved  in  this 
presentation  activity need  not  be the  same as  that  found  on  conventional  antigen 
presenting cells or B cells. In fact, such a notion is given support by the occurrence of 
Tsl activity in H-2  b and H-2  s mice, which lack serologically detectable E/C products 
(54), as well as the fact that macrophage and B cell Ia appears to be a product of I-A 
and I-E, not I-C, genes. 
As concerns Is regulation of TsF function, exemplified by the defect in H-2  b mice, 
a  similar  model  involving  I-A:C  control  of TsF  presentation  may  be  postulated. 
Recent studies have indicated that TsF molecules bear idiotypic determinants shared 
with antibody of the same antigen  specificity, particularly in systems with common 
cross-reactive  idiotypes  (55,  56).  Although  T  cell-mediated  suppression  is  antigen 
specific,  in  these  cases,  idiotype-specific effects will  appear antigen  specific.  Thus, 
triggering Ts2 by idiotype-bearing TsF would involve the activation of suppressor cells R.  N.  GERMAIN,  C.  WALTENBAUGH, AND  B.  BENACERRAF  1255 
with anti-idiotypic specificity, as proposed previously by Singer and Williams (57). 
We have recently found that Ts2 induced by azobenzenearsonate-specific TsF in A/J 
mice can be bound selectively to plastic plates coated with antiarsonate antibodies 
bearing idiotypic determinants shared  with  the TsF used  to  induce the Ts2,  thus 
confirming this prediction in at least one experimental system (50). Similarly, Eardley 
et  al.  have shown variable  portion  of the  Ig heavy chain  (VH) restriction  of T-T 
interactions in the feedback suppression loop (58). Ts2 triggering in many cases may 
therefore involve the activation of anti-idiotypic cells recognizing the idiotype of TsF, 
perhaps  in the form of idiotype-antigen complexes, since antigen is critical for Ts~ 
triggering (39). Such recognition may require TsF presentation in the context of H-2 
products, and therefore, the potential for Ir gene regulation. Thus, the failure of GT- 
TsF to cause Ts2 activation may derive from failure of certain I-A:C gene products to 
mediate effective GT-TsF idiotype presentation to Ts2 cells. An alternative explana- 
tion for the data is that the control of TsF activity resides in I-A:C-coded acceptor 
molecules on precursors of Ts2. In this case, to account for the antigen specificity of 
the defect in H-2  b mice, one would have to postulate that the I-A:C-coded acceptors 
are restricted with respect  to the specificity of the TsF  they can  recognize due to 
selective V-C (Vn:I-J) association in factor formation (see Munro and Taussig [59] for 
details). 
Finally, it should be noted that the accumulating data in the GT model, together 
with information derived from studies of many other investigators, strongly suggest 
that over-all immune regulation cannot be neatly divided into major histocompati- 
bility complex vs. idiotype directed pathways. In particular, H-2-1inked Ir genes may 
play a major role in controlling auto-anti-idiotypic responses. Thus, the products and 
activities of these two multigene clusters seem  to be  intimately interrelated in the 
activities of the complex networks that constitute the immune system. 
Summary 
The occurrence of distinct genetic defects affecting the generation of T cell-derived 
suppressor factor (TsF) or the suppressive activity of such TsF was investigated. For 
the synthetic polypeptide L-glutamic acidS°-L-tyrosine  5° (GT), it could be shown that 
the nonsuppressor strain A/J fails to produce suppressor T  cells (Tsa) capable of GT- 
TsF  generation  upon  challenge with  GT.  Conversely, B6,  another  nonsuppressor 
strain, produces GT-TsF active on other allogeneic strains such as A/J, but itself fails 
to  be  suppressed  by  this  material.  (B6A)F1  mice  both  make  GT-TsF,  and  are 
suppressed by it. Further experiments revealed that the production of GT-TsF and 
the ability to be suppressed  by GT-TsF are under the control of H-2-1inked genes. 
Finally, the defect in GT-TsF activity in B6 mice was shown to be exquisitely antigen 
specific, in that this strain can be suppressed by a closely related TsF specific for L- 
glutamic acid6°-L-alanine3°-L-tyrosine  1°.  It  is suggested that  H-2  (I)  control of sup- 
pressor T  cell (Ts) activity may reflect the involvement of I-A and I-C gene products 
in  antigen presentation  to  Ts  in  analogy with other T  cell subsets,  and  that  TsF 
function might also involve such presentation, in this case of the idiotypic structures 
of the TsF-combining site.  Predictions deriving from  this hypothesis are discussed, 
including the possibility that H-2 linked immune response genes regulate auto-anti- 
idiotypic responses in immune networks. 1256  H-2-LINKED DEFECTS IN T  SUPPRESSOR  PATHWAYS 
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